Supplementary Table S1 from Identification of a Two-Gene Biomarker Correlated with Sensitivity to Combined PARP7 Inhibition and AHR Activation in Cancer Cells
Abstract
Supplementary Table S1. The list of upregulated DEGs from the comparison between 13 synergistic lines and 5 non-synergistic lines and 18 LOO comparisons.
Fields of Study & Subjects
PARP inhibition in cancer therapy
Metabolism
Diabetes
and Cancer
Endoplasmic Reticulum Stress and Disease
Publication details
- Publication date
- 2 January 2026